The Placental Thickness and Pregnancy Outcomes in Placenta Previa Women

Launched by ASSIUT UNIVERSITY · Dec 1, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how the thickness of the placenta affects pregnancy outcomes for women with a condition called placenta previa. Placenta previa occurs when the placenta is positioned over the opening of the cervix, which can lead to bleeding and other complications during pregnancy. The study aims to explore the relationship between the thickness of the placenta during mid-pregnancy and the risk of a related condition called placenta accreta, where the placenta grows too deeply into the uterine wall. The goal is to better understand how these factors impact both the mother and the baby.

To participate in this study, women must be between 32 and 34 weeks pregnant with a single baby and have been diagnosed with placenta previa, preferably with little or no vaginal bleeding. Women who have other serious medical conditions or severe bleeding requiring immediate delivery will not be eligible. Participants will have regular follow-ups and will contribute to important research that could help improve care for future pregnancies affected by placenta previa.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Pregnant women from 32-34 weeks.
• • 2. Pregnant women with singleton pregnancy.
• • 3. Women with placenta previa.
• • 4. Placenta previa with minimal vaginal bleeding or haven't any vaginal bleeding.
• • 5. Women without any medical disorders.
• • 6. Women should be living in a nearby area to make follow-up and early transportation is reasonably possible.
• Exclusion Criteria:
• • 1. Women with severe bleeding necessitate immediate delivery.
• • 2. Women with confirmed fetal malformation.
• • 3. If associated with abruptio placentae.
• • 4. Women who will refuse to participate.